Insider holders · CIK 0001622057
Nascent Biotech Inc. · NBIO
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Sean CarrickPrincipal Executive Officer | 1,727,170 | 1,227,601 | 2,954,771 | Oct 2, 2018 · 11:55 am EDT | Form 4/A |
| Lowell Thomas HoldenCFO | 1,016,172 | 919,732 | 1,935,904 | Oct 2, 2018 · 11:53 am EDT | Form 4 |
| Brandon PriceSenior VP Business Development | 1,191,172 | — | 1,191,172 | Oct 2, 2018 · 11:58 am EDT | Form 4 |
| Douglas John KarasDirector | 60,000 | — | 60,000 | Jun 11, 2018 · 11:31 am EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.